Cargando…
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma
PURPOSE: Burkitt lymphoma (BL) is the most common tumor of non-Hodgkin’s lymphoma (NHL) in children, accounting for about 40% of cases. Although different combined short-course chemotherapies have achieved a good effect, refractory/relapsed BL has a poor prognosis with cure rates less than 30%. Chim...
Autores principales: | Yang, Xiaomin, Luo, Chengjuan, Qian, Juan, Huang, Xiaohang, Zhang, Jian, Wang, Jianmin, Luo, Changying, Qin, Xia, Li, Benshang, Chen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510403/ https://www.ncbi.nlm.nih.gov/pubmed/37736096 http://dx.doi.org/10.3389/fimmu.2023.1219872 |
Ejemplares similares
-
Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
por: Wang, Tianyi, et al.
Publicado: (2021) -
Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
por: Wu, Jiaying, et al.
Publicado: (2022) -
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report
por: Cheng, Ling, et al.
Publicado: (2022) -
Toxoplasma gondii infection in children after allogeneic hematopoietic stem cell transplantation: A case report and literature review
por: Luo, Lijuan, et al.
Publicado: (2021) -
Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients
por: Rotolo, Antonia, et al.
Publicado: (2023)